These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]. Zarakolu P, Hasçelik G, Unal S. Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842 [Abstract] [Full Text] [Related]
23. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul]. Ozyurt M, Haznedaroğlu T, Sahiner F, Oncül O, Ceylan S, Ardiç N, Erdemoğlu A. Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421 [Abstract] [Full Text] [Related]
24. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, Van Asbeck E, Roskott AM, Froeling F, Rozenberg-Arska M, Hoepelman IM. Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732 [Abstract] [Full Text] [Related]
25. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Koksal F, Ak K, Kucukbasmaci O, Samasti M. Chemotherapy; 2009 May; 55(4):293-7. PubMed ID: 19521075 [Abstract] [Full Text] [Related]
26. Antimicrobial resistance and plasmid profiles of urinary Escherichia coli isolates from Jordanian patients. Shehabi AA, Mahafzah AM, Al-Khalili KZ. East Mediterr Health J; 2004 May; 10(3):322-8. PubMed ID: 16212208 [Abstract] [Full Text] [Related]
27. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). Nys S, Terporten PH, Hoogkamp-Korstanje JA, Stobberingh EE, Susceptibility Surveillance Study Group. J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487 [Abstract] [Full Text] [Related]
28. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Arch Intern Med; 2008 Sep 22; 168(17):1897-902. PubMed ID: 18809817 [Abstract] [Full Text] [Related]
29. [Changes of antimicrobial resistance among clinical isolates of Escherichia coil in Shanghai 1990-2004]. Zhang YY, Zhu DM, Hu FP, Wu S, Wang F. Zhonghua Yi Xue Za Zhi; 2006 Jan 03; 86(1):12-6. PubMed ID: 16606528 [Abstract] [Full Text] [Related]
30. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA. BJU Int; 2012 Apr 03; 109(8):1198-206. PubMed ID: 21883861 [Abstract] [Full Text] [Related]
31. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B. Int J Antimicrob Agents; 2005 Jul 03; 26(1):75-7. PubMed ID: 15955672 [Abstract] [Full Text] [Related]
32. [Etiologic agents and risk factors in nosocomial urinary tract infections]. Akkoyun S, Kuloğlu F, Tokuç B. Mikrobiyol Bul; 2008 Apr 03; 42(2):245-54. PubMed ID: 18697422 [Abstract] [Full Text] [Related]
33. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences. Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for E. coli Urinary Pathogens. Rev Esp Quimioter; 2007 Jun 03; 20(2):206-10. PubMed ID: 17893757 [Abstract] [Full Text] [Related]
34. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG. Singapore Med J; 2006 Apr 03; 47(4):281-5. PubMed ID: 16572238 [Abstract] [Full Text] [Related]
35. Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital. Al-Tawfiq JA, Anani AA. Chemotherapy; 2009 Apr 03; 55(2):127-31. PubMed ID: 19188712 [Abstract] [Full Text] [Related]
36. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal. Srinivasa H, Parija SC, Bhattacharya S, Sehgal R. J Commun Dis; 1999 Mar 03; 31(1):45-7. PubMed ID: 10810586 [Abstract] [Full Text] [Related]
37. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, Usluer G, Colak E. Saudi Med J; 2006 May 03; 27(5):608-12. PubMed ID: 16680246 [Abstract] [Full Text] [Related]
38. Increasing prevalence of antibiotic resistance and multi drug resistance among uropathogens. Anandkumar H, Kapur I, Dayanand A. J Commun Dis; 2003 Jun 03; 35(2):102-8. PubMed ID: 15562956 [Abstract] [Full Text] [Related]
39. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, NAUTICA Group. Int J Antimicrob Agents; 2005 Nov 03; 26(5):380-8. PubMed ID: 16243229 [Abstract] [Full Text] [Related]
40. Class 1 integrons and multidrug resistance among Escherichia coli isolates from human stools. Phongpaichit S, Wuttananupan K, Samasanti W. Southeast Asian J Trop Med Public Health; 2008 Mar 03; 39(2):279-87. PubMed ID: 18564714 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]